Press releases

28 Sep 2015

Synthon Reports Promising Initial Results from Phase I Trial with anti-HER2 ADC SYD985

read more
03 Aug 2015

Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis

read more
28 Apr 2015

Synthon Announces Successful Outcomes from the Open-label extension of the Phase III GATE Study of Synthon’s Glatiramer Acetate

read more